Area of research
Genetics · Oncology
Research interest
Research interests include Glioma Diagnosis and Treatment, CAR-T cell therapy research, Neurofibromatosis and Schwannoma Cases, and Neuroblastoma Research and Treatments.
The promise of immunotherapy for central nervous system tumours
Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review
CTIM-05. HUMANIZED ANTI-CAR ANTIBODIES AFFECT DURABLE RESPONSE TO GD2-CAR T-CELLS IN DIFFUSE MIDLINE GLIOMA
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Tumor inflammation-associated neurotoxicity
Abstract 959: Immune signatures of GD2 CAR T cell activity in H3K27M+ diffuse midline glioma patients
IMMU-05. TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Stroke Mimics Are Not Benign in Immunocompromised Children
Abstract CT031: GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas
OMIC-11. SINGLE CELL RNA SEQUENCING FROM THE CSF OF SUBJECTS WITH H3K27M+ DIPG/DMG TREATED WITH GD2 CAR T-CELLULAR THERAPY
IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Genetics · Oncology →